Navigation Links
Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
Date:12/11/2012

(Philadelphia, PA) An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs. They have shown in mice with cancer that even after treatment with the highly effective imatinib (Gleevec), stem cells that become resistant to these drugs tyrosine kinase inhibitors (TKIs) may continue to foster DNA damage, potentially leading to disease relapse and a downward spiral to a much more deadly "blast" stage of leukemia.

Identifying a source of such genomic instability may help investigators eventually devise new treatment strategies against drug-resistant CML and other difficult-to-treat diseases.

"We showed that mice that mimic human CML are continuing to accumulate DNA damage despite treatment with imatinib," said senior investigator Tomasz Skorski, MD, PhD, Professor of Microbiology and Immunology at Temple University School of Medicine. "This implies that whether a patient with CML is being treated or not, DNA damage can continue to accumulate and can confer resistance and possibly lead to relapse in some patients." Dr. Skorski, first author Elisabeth Bolton Gillespie, a graduate PhD student in the Department of Microbiology and Immunology, and their co-workers presented their findings December 11 at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta.

In CML, an enzyme called ABL1 goes into overdrive because of a chromosomal mix-up that occurs during blood cell development. The genes ABL1 and BCR become fused and produce a hybrid BCR-ABL1 enzyme that is always turned on. This overactive BCR-ABL1 protein drives the excessive production of white blood cells that is the hallmark of CML.

While treatment with imatinib is usually effective in control
'/>"/>

Contact: Steven Benowitz
steven.benowitz@tuhs.temple.edu
215-707-4784
Temple University Health System
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Foreign multidrug resistant bacteria contained in Toronto hospital
2. Ponatinib acts against the most resistant types of chronic myeloid leukemia
3. New finding gives clues for overcoming tamoxifen-resistant breast cancer
4. Moffitt researcher investigates 2-drug synergy to treat drug-resistant chronic myeloid leukemia
5. Discovery of essential genes for drug-resistant bacteria reveals new, high-value drug targets
6. Nationwide Childrens Hospital develops prototype for safer, child-resistant spray bottle
7. Pain drug can kill resistant tuberculosis
8. Molecule shows effectiveness against drug-resistant myeloma
9. Alarming Rise Seen in Drug-Resistant Tuberculosis
10. Possible therapy for tamoxifen resistant breast cancer identified
11. Renal sympathetic denervation improves physical and mental health in resistant hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive high-tech ... marketing of a series of induction heating equipment. Today, ... of induction brazing equipments . , According to ... refers to the joining of two or more ... manager says that there are fundamental differences in the ...
(Date:12/25/2014)... 2014 The microscopy market is ... to reach $5,756.0 million by 2019. Optical microscopy ... The electron microscopes product segment is expected to ... , Rising focus on nanotechnology, technological advancements, and ... microscopy market. , Get Full Copy of Report ...
(Date:12/25/2014)... The click strand woven ... and durability. Today, the business announces a click ... until Jan. 30, 2015. , Click strand woven ... BambooFlooringChina.com is a well-known brand in the bamboo ... find a reliable bamboo flooring supplier. , “We ...
(Date:12/25/2014)... December 26, 2014 The report “TS-1 ... focuses on the current treatment landscape, unmet needs, current ... TS-1 is an anti-cancer drug which is typically used ... is also used for treating gastric cancer and pancreatic ... potassium. The drug was first approved in 1999 in ...
(Date:12/25/2014)... “Every three months the trends for evening ... dress will be one of the hottest styles in the ... Today, the company releases 26 A-line sweetheart evening dresses, and ... , “We are trying our best to help a ... designs. Along with affordable prices, we provide discounted delivery costs ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... with tedious record-keepingSEATTLE, March 31 Iccomplish, Inc ... software that takes the tediousness out of corporate ... corporations can remain compliant with corporate reporting laws ... the cost of hiring a corporate attorney. Failure ...
... SHANGHAI, March 31 /PRNewswire-Asia/ -- WuXi AppTec announced today ... the U.S. Food and,Drug Administration (FDA) without the issuance ... non compliance issues after a site inspection. , ... WuXi,s Bioanalytical Services (BAS) was ...
... When beloved miniature Dachshund Frederick ruptured a disc ... and Diane Smith, that he would likely never walk ... dire prognosis, the Smiths sought out alternative treatments, and ... other medical challenges, including lupus, Addison,s disease and encephalitis. ...
... Varian,s VariSeed(TM) 8.0 Offers Advantages in Simplifying Dose ... Va., March 31 Prostate cancer patients have ... that enables improvements in the precision and speed ... Medical Systems (NYSE: VAR ) is ...
... COLUMBIA, Md. and SAN JOSE, Calif., March 31 ... and technologies, today announced that it has entered into ... the embedded computing engine for ... device. After initial delivery of units, Authentidate will have ...
... convenience for physicians, enhances content delivery for health ... ZIXI ), the leader in e-prescribing, ... of ZixCorp,s industry leading e-prescribing application. This ... which leverage the most current versions of industry ...
Cached Medicine News:Health News:Automate Corporate Minutes and Resolutions; Stop IRS Woes Before They Happen 2Health News:WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection 2Health News:Miniature Dachshund's Legacy Inspires YourDogHealth.com to Help Other Canines 2Health News:Miniature Dachshund's Legacy Inspires YourDogHealth.com to Help Other Canines 3Health News:Prostate Cancer Patients in US and Europe Receive Treatments Using Enhanced Seed Prostate Brachytherapy Software 2Health News:Prostate Cancer Patients in US and Europe Receive Treatments Using Enhanced Seed Prostate Brachytherapy Software 3Health News:Eurotech and Authentidate Enter into a Contract for Embedded Computer for Home-Based Medical Device 2Health News:Eurotech and Authentidate Enter into a Contract for Embedded Computer for Home-Based Medical Device 3Health News:Zix Corporation Introduces Powerful New Version of PocketScript 2Health News:Zix Corporation Introduces Powerful New Version of PocketScript 3
(Date:12/22/2014)... LAWRENCE, Mass. , Dec. 22, 2014 /PRNewswire/ ... a leading manufacturer of innovative dialysis products, announced ... (FDA) has cleared its System One™ to perform ... sleeping, known as home nocturnal hemodialysis. NxStage,s® System ... cleared by the FDA for this indication. ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today issued the following open letter to ... , Dr. Med. Sc. Dear RXi ... a number of inaccurate statements posted on certain ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... Decision Resources, one of the world,s leading research ... that, through 2019, an expanding aging population and increases ... percent annual growth in the chronic obstructive pulmonary disease ... findings from the topic entitled Chronic Obstructive Pulmonary ...
... -- DALLAS, Texas, August 31, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
Cached Medicine Technology:An Expanding Aging Population and Increases in Diagnosis and Drug Treatment Will Fuel Steady 4.6 Percent Annual Growth in the Chronic Obstructive Pulmonary Drug Market 2The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 2The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 3The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 4The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 5The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 6The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 7The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 8The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 9
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: